Pandemic Darlings The pandemic economy, in original documents
Home Source documents Senate Commerce Committee Statement to Senate, No. 1614 — State of New Jersey (March 14, 2022)

Senate Commerce Committee Statement to Senate, No. 1614 — State of New Jersey (March 14, 2022)

Summary

A Senate Commerce Committee statement to the Senate on Senate Bill No. 1614, State of New Jersey, dated March 14, 2022, reporting the bill favorably. The bill caps out-of-pocket costs for covered persons prescribed insulin, an epinephrine auto-injector device or a prescription asthma inhaler, with no deductible allowed. Copayments or coinsurance are capped at $35 per 30-day supply of insulin, $25 for epinephrine auto-injector devices and $50 for prescription asthma inhalers per 30-day supply. The standards apply to service corporations, health insurance policies, health maintenance organizations and individual and small employer plans, and the statement says the bill is identical to Assembly Bill No. 2839.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Senate Commerce Committee Statement to Senate, No. 1614 — State of New Jersey (March 14, 2022).” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/s1614-scm-statement-3-14-22-4fe41ab5b9/, SHA-256 e89ba1a1847ec078e6b99dbe23e3295c0c8eaf300fa350b3170ba59161cfe591.

Full text

SENATE COMMERCE COMMITTEE

STATEMENT TO

SENATE, No.
1614

STATE
OF NEW JERSEY

DATED: MARCH
14, 2022

The
Senate Commerce Committee reports favorably Senate Bill No. 1614.

This
bill places a flat cap on the out-of-pocket contribution for any covered person
prescribed insulin, an epinephrine auto-injector device, or a prescription
asthma inhaler across insurance providers. Coverage for these items may not be
subject to any deductible, and copayments or coinsurance are capped at $35 per
30-day supply of insulin, $25 for epinephrine auto-injector devices per 30-day
supply, and $50 for prescription asthma inhalers per 30-day supply.

These
coverage standards apply to individual or group hospital service corporations,
medical service corporations, and health service corporations as well as
individual and group health insurance policies and health maintenance
organizations. Additionally, the bill extends these coverage standards to
individual and small employer health benefits plans and require that the State
Health Benefits Commission and the School Employee’s Health Benefits Commission
ensure that their contracts comply with the coverage standards.

As reported
by the committee, this bill is identical to Assembly Bill No. 2839.

File and source

File
2022-03-14_SCM_S1614_S1.htm
Size
5,549 bytes
SHA-256
e89ba1a1847ec078e6b99dbe23e3295c0c8eaf300fa350b3170ba59161cfe591
Our copy
2022-03-14_SCM_S1614_S1.htm
Original
No public link identified.
Back to top